{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:48:10Z","timestamp":1794502090913,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The WHO Global Malaria Programme advocates for a comprehensive, strategic approach to managing insecticide resistance, highlighting the importance of using multiple insecticides with different modes of action through rotations and combinations. To slow the spread of resistance, it is essential to develop and evaluate new formulations that feature unique modes of action and extended residual effects. Addressing this need, Mitsui Chemicals Crop &amp; Life Solutions, Inc., developed VECTRON\u2122 T500, a new indoor residual spraying (IRS) formulation using broflanilide, applied at a dosage of 100\u00a0mg AI\/m\n                      <jats:sup>2<\/jats:sup>\n                      . This formulation was tested in a Phase III community trial, alongside Actellic\n                      <jats:sup>\u00ae<\/jats:sup>\n                      300CS, a commonly used IRS product containing pirimiphos-methyl, applied at the recommended dosage of 1000\u00a0mg AI\/m\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Monthly WHO wall cone bioassays were performed to assess the efficacy of the interventions using three mosquito strains: the laboratory-bred, insecticide-susceptible\n                      <jats:italic>Anopheles gambiae\u00a0<\/jats:italic>\n                      s.s. Kisumu strain, the insecticide-resistant\n                      <jats:italic>Anopheles coluzzii<\/jats:italic>\n                      VKPer strain, and wild\n                      <jats:italic>Anopheles gambiae<\/jats:italic>\n                      s.l. mosquitoes from the Vall\u00e9e du Kou, where the study was conducted. Vector surveillance was carried out to compare the results between sites treated with VECTRON\u2122 T500, Actellic\n                      <jats:sup>\u00ae<\/jats:sup>\n                      300CS, and an untreated control site. In addition, any reported adverse effects were closely monitored to evaluate the community\u2019s acceptance of VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      VECTRON\u2122 T500 consistently achieved 100% mortality across all wall types for both susceptible and resistant mosquito strains over the 12-month period. In comparison, Actellic\n                      <jats:sup>\u00ae<\/jats:sup>\n                      300CS induced &lt; 80% mortality for both strains, irrespective of the wall substrate. When assessing delayed mortality in\n                      <jats:italic>An. gambiae<\/jats:italic>\n                      s.l. mosquitoes collected from sites treated with Actellic\n                      <jats:sup>\u00ae<\/jats:sup>\n                      300CS (VK1) and VECTRON\u2122 T500 (VK3), a statistically significant difference was noted after a 72-h holding period compared to the control site (RR\u2009=\u20090.51, CI95%\u2009=\u2009[0.31\u20130.6],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0026). Additionally, no adverse events were reported in households sprayed with VECTRON\u2122 T500.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The residual efficacy of VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500 extended for 12\u00a0months post-spraying, effectively covering the full malaria transmission season while maintaining high mortality rates in pyrethroid-resistant malaria vectors. VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500 demonstrated non-inferiority in performance compared to Actellic\n                      <jats:sup>\u00ae<\/jats:sup>\n                      300CS, the standard reference product. This new IRS formulation has the potential to play a crucial role in managing insecticide resistance by being integrated into a rotational strategy alongside other IRS products containing insecticides with different modes of action.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-024-06577-y","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T04:36:52Z","timestamp":1732336612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-lasting residual efficacy of a new indoor residual spraying product, VECTRON\u2122 T500 (broflanilide), against pyrethroid-resistant malaria vectors and its acceptance in a community trial in Burkina Faso"],"prefix":"10.1186","volume":"17","author":[{"given":"Aristide Sawdetuo","family":"Hien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koama","family":"Bayili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samina","family":"Maiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Welbeck","family":"Oumbouke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Birba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieudonn\u00e9 Diloma","family":"Soma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adissa Ya","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine Ouissamien","family":"Karama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlize","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Snetselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawase","family":"Ayumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidzabda","family":"Kompaor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roch Kounbobr","family":"Dabir\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulaye","family":"Diabat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"6577_CR1","volume-title":"WHO Malaria Policy Advisory Group (MPAG) meeting, October 2022","author":"WHO","year":"2022","unstructured":"WHO. WHO Malaria Policy Advisory Group (MPAG) meeting, October 2022. Geneva: World Health Organization; 2022."},{"key":"6577_CR2","volume-title":"Global plan for insecticide resistance management in malaria vectors","author":"WHO","year":"2012","unstructured":"WHO. Global plan for insecticide resistance management in malaria vectors. Geneva: World Health Organization; 2012."},{"key":"6577_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-016-1201-1","volume":"15","author":"RM Oxborough","year":"2016","unstructured":"Oxborough RM. Trends in US President\u2019s Malaria Initiative-funded indoor residual spray coverage and insecticide choice in sub-Saharan Africa (2008\u20132015): urgent need for affordable, long-lasting insecticides. Malar J. 2016;15:1\u20139.","journal-title":"Malar J"},{"key":"6577_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-03216-6","volume":"19","author":"JAA Tangena","year":"2020","unstructured":"Tangena JAA, Hendriks CM, Devine M, Tammaro M, Trett AE, Williams I, et al. Indoor residual spraying for malaria control in sub-Saharan Africa 1997 to 2017: an adjusted retrospective analysis. Malar J. 2020;19:1\u201315.","journal-title":"Malar J"},{"key":"6577_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-017-2417-9","volume":"10","author":"C Antonio-Nkondjio","year":"2017","unstructured":"Antonio-Nkondjio C, Sonhafouo-Chiana N, Ngadjeu CS, Doumbe-Belisse P, Talipouo A, Djamouko-Djonkam L, et al. Review of the evolution of insecticide resistance in main malaria vectors in Cameroon from 1990 to 2017. Parasit Vectors. 2017;10:1\u201314.","journal-title":"Parasit Vectors"},{"key":"6577_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.17795\/jhealthscope-9840","volume":"2","author":"K Karunamoorthi","year":"2013","unstructured":"Karunamoorthi K, Sabesan S. Insecticide resistance in insect vectors of disease with special reference to mosquitoes: a potential threat to global public health. Health Scope. 2013;2:4\u201318. https:\/\/doi.org\/10.5812\/jhs.9840.","journal-title":"Health Scope"},{"key":"6577_CR7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/genes10100790","volume":"10","author":"E Elanga-Ndille","year":"2019","unstructured":"Elanga-Ndille E, Nouage L, Ndo C, Binyang A, Assatse T, Nguiffo-Nguete D, et al. The G119S acetylcholinesterase (Ace-1) target site mutation confers carbamate resistance in the major malaria vector Anopheles gambiae from Cameroon: a challenge for the coming IRS Implementation. Genes. 2019;10:790.","journal-title":"Genes"},{"key":"6577_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-13-37","volume":"13","author":"RM Oxborough","year":"2014","unstructured":"Oxborough RM, Kitau J, Jones R, Feston E, Matowo J, Mosha FW, et al. Long-lasting control of Anopheles arabiensis by a single spray application of micro-encapsulated pirimiphos-methyl (Actellic\u00ae 300 CS). Malar J. 2014;13:1\u201316.","journal-title":"Malar J"},{"key":"6577_CR9","unstructured":"WHO. Report of the sixteenth WHOPES working group meeting: WHO\/HQ, Geneva, 22\u201330 July 2013: review of Pirimiphos-methyl 300 CS, Chlorfenapyr 240 SC, Deltamethrin 62.5 SC-PE, Duranet LN, Netprotect LN, Yahe LN, Spinosad 83.3 Monolayer DT, Spinosad 25 Extended release GR\u00a0(No. WHO\/HTM\/NTD\/WHOPES\/2013.6). World Health Organization, 2013."},{"key":"6577_CR10","volume-title":"WHO prequalification vector control","author":"WHO","year":"2020","unstructured":"WHO. WHO prequalification vector control. Geneva: World Health Organization; 2020."},{"key":"6577_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1584\/jpestics.D18-088","volume":"44","author":"H Katsuta","year":"2019","unstructured":"Katsuta H, Nomura M, Wakita T, Daido H, Kobayashi Y, Kawahara A, et al. Discovery of broflanilide, a novel insecticide. J Pestic Sci. 2019;44:120\u20138.","journal-title":"J Pestic Sci"},{"key":"6577_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-03466-4","volume":"19","author":"RS Lees","year":"2020","unstructured":"Lees RS, Ambrose P, Williams J, Morgan J, Praulins G, Ingham VA, et al. Tenebenal: a meta-diamide with potential for use as a novel mode of action insecticide for public health. Malar J. 2020;19:1\u201317.","journal-title":"Malar J"},{"key":"6577_CR13","unstructured":"IRAC. Mode of Action Classification Scheme. IRAC, 2019.Version 9.32019 January; Version 9.3."},{"key":"6577_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.bmc.2015.08.008","volume":"24","author":"T Nakao","year":"2016","unstructured":"Nakao T, Banba S. Broflanilide: a meta-diamide insecticide with a novel mode of action. Bioorg Med Chem. 2016;24:372\u20137.","journal-title":"Bioorg Med Chem"},{"key":"6577_CR15","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1038\/s41598-021-86935-3","volume":"11","author":"C Ngufor","year":"2021","unstructured":"Ngufor C, Govoetchan R, Fongnikin A, Vigninou E, Syme T, Akogbeto M, et al. Efficacy of broflanilide (VECTRON T500), a new meta-diamide insecticide, for indoor residual spraying against pyrethroid-resistant malaria vectors. Sci Rep. 2021;11:7976.","journal-title":"Sci Rep"},{"key":"6577_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.12688\/gatesopenres.13578.2","volume":"6","author":"K Bayili","year":"2022","unstructured":"Bayili K, Ki HD, Bayili B, Sow B, Ouattara A, Small G, et al. Laboratory and experimental hut trial evaluation of VECTRON\u2122 T500 for indoor residual spraying (IRS) against insecticide resistant malaria vectors in Burkina Faso. Gates Open Res. 2022;6:57.","journal-title":"Gates Open Res"},{"key":"6577_CR17","doi-asserted-by":"publisher","first-page":"e0248026","DOI":"10.1371\/journal.pone.0248026","volume":"16","author":"J Snetselaar","year":"2021","unstructured":"Snetselaar J, Rowland MW, Manunda BJ, Kisengwa EM, Small GJ, Malone DJ, et al. Efficacy of indoor residual spraying with broflanilide (TENEBENAL), a novel meta-diamide insecticide, against pyrethroid-resistant anopheline vectors in northern Tanzania: an experimental hut trial. PLoS ONE. 2021;16:e0248026.","journal-title":"PLoS ONE"},{"key":"6577_CR18","volume-title":"List of WHO prequalified vector control products","author":"WHO","year":"2023","unstructured":"WHO. List of WHO prequalified vector control products. Geneva: World Health Organization; 2023."},{"key":"6577_CR19","doi-asserted-by":"publisher","first-page":"e0276246","DOI":"10.1371\/journal.pone.0276246","volume":"18","author":"R Govoetchan","year":"2023","unstructured":"Govoetchan R, Odjo A, Todjinou D, Small G, Fongnikin A, Ngufor C. Investigating discriminating concentrations for monitoring susceptibility to broflanilide and cross resistance to other insecticide classes in Anopheles gambiae sensu lato, using the new WHO bottle bioassay method. PLoS ONE. 2023;18:e0276246.","journal-title":"PLoS ONE"},{"key":"6577_CR20","doi-asserted-by":"publisher","first-page":"22359","DOI":"10.1038\/s41598-022-26990-6","volume":"12","author":"NM Portwood","year":"2022","unstructured":"Portwood NM, Shayo MF, Tungu PK, Mbewe NJ, Mlay G, Small G, et al. multi-centre discriminating concentration determination of broflanilide and potential for cross-resistance to other public health insecticides in Anopheles vector populations. Sci Rep. 2022;12:22359.","journal-title":"Sci Rep"},{"key":"6577_CR21","doi-asserted-by":"publisher","first-page":"17852","DOI":"10.1038\/s41598-023-45047-w","volume":"13","author":"C Ngufor","year":"2023","unstructured":"Ngufor C, Govoetchan R, Fongnikin A, Hueha C, Ahoga J, Syme T, et al. Community evaluation of VECTRON\u2122 T500, a broflanilide insecticide, for indoor residual spraying for malaria vector control in central Benin; a two arm non-inferiority cluster randomised trial. Sci Rep. 2023;13:17852.","journal-title":"Sci Rep"},{"key":"6577_CR22","first-page":"71","volume":"12","author":"T Cherileila","year":"2024","unstructured":"Cherileila T, Aristide HS, Nad\u00e8ge K, Bazoma B, Abdoulaye O, Patrice T, et al. Cholinesterase activity as an indicator of health risks among Kou Valley farmers. J Biosci Med. 2024;12:71\u201386.","journal-title":"J Biosci Med"},{"key":"6577_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1365-3156.2006.01605.x","volume":"11","author":"A Diabate","year":"2006","unstructured":"Diabate A, Chandre F, Rowland M, Nguessan R, Duchon S, Dabire KR, et al. The indoor use of plastic sheeting pre-impregnated with insecticide for control of malaria vectors. Trop Med Int Health. 2006;11:597\u2013603.","journal-title":"Trop Med Int Health"},{"key":"6577_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-7-188","volume":"7","author":"KR Dabir\u00e9","year":"2008","unstructured":"Dabir\u00e9 KR, Diabat\u00e9 A, Djogbenou L, Ouari A, N\u2019Guessan R, Ou\u00e9draogo JB, et al. Dynamics of multiple insecticide resistance in the malaria vector Anopheles gambiae in a rice growing area in South-Western Burkina Faso. Malar J. 2008;7:1\u20139.","journal-title":"Malar J"},{"key":"6577_CR25","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.trstmh.2009.01.008","volume":"103","author":"KR Dabir\u00e9","year":"2009","unstructured":"Dabir\u00e9 KR, Diabat\u00e9 A, Namountougou M, Toe KH, Ouari A, Kengne P, et al. Distribution of pyrethroid and DDT resistance and the L1014F kdr mutation in Anopheles gambiae sl from Burkina Faso (West Africa). Trans R Soc Trop Med Hyg. 2009;103:1113\u201320.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6577_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-3156.2009.02243.x","volume":"14","author":"KR Dabir\u00e9","year":"2009","unstructured":"Dabir\u00e9 KR, Diabat\u00e9 A, Namontougou M, Djogbenou L, Kengne P, Simard F, et al. Distribution of insensitive acetylcholinesterase (ace-1R) in Anopheles gambiae sl populations from Burkina Faso (West Africa). Trop Med Int Health. 2009;14:396\u2013403.","journal-title":"Trop Med Int Health"},{"key":"6577_CR27","doi-asserted-by":"publisher","first-page":"e48412","DOI":"10.1371\/journal.pone.0048412","volume":"7","author":"M Namountougou","year":"2012","unstructured":"Namountougou M, Simard F, Baldet T, Diabat\u00e9 A, Ou\u00e9draogo JB, Martin T, et al. Multiple insecticide resistance in Anopheles gambiae sl populations from Burkina Faso, West Africa. PLoS ONE. 2012;7:e48412.","journal-title":"PLoS ONE"},{"key":"6577_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-020-04563-8","volume":"14","author":"DD Soma","year":"2021","unstructured":"Soma DD, Zogo B, Hien DFDS, Hien AS, Kabor\u00e9 DA, Kientega M, et al. Insecticide resistance status of malaria vectors Anopheles gambiae (sl) of southwest Burkina Faso and residual efficacy of indoor residual spraying with microencapsulated pirimiphos-methyl insecticide. Parasit Vectors. 2021;14:1\u20139.","journal-title":"Parasit Vectors"},{"key":"6577_CR29","unstructured":"WHO. SumiShield 50WG: World Health Organization. 2018. https:\/\/extranet.who.int\/pqweb\/vector-control-product\/sumishield-50wg. Accessed 03 Apr 2024."},{"key":"6577_CR30","unstructured":"WHO. List of WHO prequalified Vector Control Products. 2020. https:\/\/extranet.who.int\/pqweb\/vector-control-products\/prequalified-productlist. Accessed 03 Apr 2024."},{"key":"6577_CR31","first-page":"1","volume":"55","author":"MT Gillies","year":"1987","unstructured":"Gillies MT, Coetzee M. A supplement to the Anophelinae of Africa South of the Sahara. Publ S Afr Inst Med Res. 1987;55:1\u2013143.","journal-title":"Publ S Afr Inst Med Res"},{"key":"6577_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jmedent\/25.1.9","volume":"25","author":"JC Beier","year":"1988","unstructured":"Beier JC, Perkins PV, Wirtz RA, Korus J, Diggs D, et al. Bloodmeal identification by direct enzyme-linked immunosorbent assay (ELISA), tested on Anopheles (Diptera: Culicidae) in Kenya. J Med Entomol. 1988;25:9\u201316.","journal-title":"J Med Entomol"},{"key":"6577_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-7-163","volume":"7","author":"F Santolamazza","year":"2008","unstructured":"Santolamazza F, Mancini E, Simard F, Qi Y, Tu Z, Torre della A. Insertion polymorphisms of SINE200 retrotransposons within speciation islands of Anopheles gambiae molecular forms. Malar J. 2008;7:1\u201310.","journal-title":"Malar J"},{"key":"6577_CR34","unstructured":"WHO. Guidelines for testing mosquito adulticides for indoor residual spraying and treatment of mosquito nets (No. WHO\/CDS\/NTD\/WHOPES\/GCDPP\/2006.3). World Health Organization; 2006."},{"key":"6577_CR35","unstructured":"Brogdon W, Chan A. Guideline for evaluating insecticide resistance in vectors using the CDC bottle bioassay. USA: CDC Atlanta, 2010."},{"key":"6577_CR36","unstructured":"Centers for Disease Control and Prevention. Global manual for Evaluating Insecticide resistance in vectors using the CDC bottle bioassay. 2011. 30p. https:\/\/www.cdc.gov\/malaria\/resources\/pdf\/fsp\/ir_manual\/Global-Insect-Resist-Bottle-Bioassay-508.pdf. Accessed 03 Apr 2024."},{"key":"6577_CR37","unstructured":"WHO. Global Plan for Insecticide Resistance Management in Malaria Vectors. Geneva, 561 Switzerland: World Health Organization, 2012."},{"key":"6577_CR38","volume-title":"World malaria report","author":"WHO","year":"2022","unstructured":"WHO. World malaria report. Geneva: World Health Organization; 2022."},{"key":"6577_CR39","volume-title":"Test procedures for insecticide resistance monitoring in malaria vector mosquitoes","author":"WHO","year":"2016","unstructured":"WHO. Test procedures for insecticide resistance monitoring in malaria vector mosquitoes. Geneva: World Health Organization; 2016."},{"key":"6577_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-015-0693-4","volume":"14","author":"AP Mnzava","year":"2015","unstructured":"Mnzava AP, Knox TB, Temu EA, Trett A, Fornadel C, Hemingway J, et al. Implementation of the global plan for insecticide resistance management in malaria vectors: progress, challenges and the way forward. Malar J. 2015;14:1\u20139.","journal-title":"Malar J"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-024-06577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-024-06577-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-024-06577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T09:05:13Z","timestamp":1732611913000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-024-06577-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6577"],"URL":"https:\/\/doi.org\/10.1186\/s13071-024-06577-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4913757\/v1","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An information consent form, translated into the local language, was provided to the heads of households. Furthermore, informed consent was obtained from the volunteer mosquito collectors. The mosquito collectors were exclusively male individuals between the ages of 18 and 40, members of the local community, who were recruited and trained for this role. Collectors were permitted to withdraw from the trial at any time. They were subject to regular examination by a study physician for clinical indications of malaria while participating in the study. In the event of a positive diagnosis, they were referred to the nearest local health centre for free treatment. Furthermore, mosquito collectors were afforded free access to malaria diagnosis and treatment for a period of up to 1 month following the conclusion of the study. A study physician at the local public health facility was responsible for the administration of all medical care under the project. Spray operators were required to be male, at least 18\u00a0years of age, physically fit, and in good health. They were also expected to have no obvious disabilities that would limit their mobility and to possess sufficient literacy in French to enable them to follow all insecticide handling procedures in a safe manner. Prior to their participation in the study, all participants, including heads of households and mosquito collectors, provided written informed consent. Furthermore, this study was approved by the ethics committee and registered under the number 15-2021\/CEIRES on April 6, 2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"484"}}